1 trial result announced this day (US Eastern).
| Time (ET) | Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|---|
| 7:04 AM | Pemvidutide Alcohol Use Disorder (AUD) | Altimmune (ALT) | Met | $2.96 | $3.00 | +1.35% |
Updated from the previous day
| Drug / result | Company | Outcome | Before | 24h later | 24h move |
|---|---|---|---|---|---|
| ML-007C Schizophrenia | MapLight Therapeutics (MPLT) | Met | $36.56 | $9.63 | −73.66% |
For information only. Not investment or medical advice. Prices are historical, from consolidated market data, and may contain errors. Always check the original source.